Sargent Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.84M | Buy |
5,141
+1,448
| +39% | +$1.08M | 0.52% | 42 |
|
2025
Q1 | $3.05M | Buy |
3,693
+1,154
| +45% | +$953K | 0.49% | 45 |
|
2024
Q4 | $2.02M | Sell |
2,539
-87
| -3% | -$69.4K | 0.33% | 63 |
|
2024
Q3 | $2.33M | Buy |
2,626
+63
| +2% | +$55.8K | 0.42% | 51 |
|
2024
Q2 | $2.32M | Buy |
2,563
+264
| +11% | +$239K | 0.47% | 49 |
|
2024
Q1 | $1.79M | Buy |
2,299
+138
| +6% | +$107K | 0.39% | 54 |
|
2023
Q4 | $1.26M | Sell |
2,161
-290
| -12% | -$169K | 0.28% | 72 |
|
2023
Q3 | $1.32M | Buy |
2,451
+137
| +6% | +$73.6K | 0.32% | 63 |
|
2023
Q2 | $1.09M | Buy |
2,314
+152
| +7% | +$71.3K | 0.26% | 76 |
|
2023
Q1 | $758K | Buy |
2,162
+33
| +2% | +$11.6K | 0.2% | 92 |
|
2022
Q4 | $779K | Buy |
2,129
+25
| +1% | +$9.15K | 0.24% | 86 |
|
2022
Q3 | $701K | Sell |
2,104
-115
| -5% | -$38.3K | 0.22% | 88 |
|
2022
Q2 | $719K | Sell |
2,219
-130
| -6% | -$42.1K | 0.22% | 89 |
|
2022
Q1 | $673K | Hold |
2,349
| – | – | 0.17% | 100 |
|
2021
Q4 | $649K | Sell |
2,349
-80
| -3% | -$22.1K | 0.15% | 105 |
|
2021
Q3 | $561K | Hold |
2,429
| – | – | 0.14% | 108 |
|
2021
Q2 | $558K | Sell |
2,429
-20
| -0.8% | -$4.59K | 0.13% | 112 |
|
2021
Q1 | $458K | Buy |
2,449
+150
| +7% | +$28.1K | 0.12% | 122 |
|
2020
Q4 | $388K | Hold |
2,299
| – | – | 0.12% | 126 |
|
2020
Q3 | $340K | Buy |
2,299
+200
| +10% | +$29.6K | 0.12% | 117 |
|
2020
Q2 | $343K | Buy |
2,099
+485
| +30% | +$79.3K | 0.13% | 110 |
|
2020
Q1 | $224K | Buy |
+1,614
| New | +$224K | 0.1% | 126 |
|